Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 1;14(3):766.
doi: 10.3390/cancers14030766.

Molecular Mechanisms Related with Oligometastatic Prostate Cancer-Is It Just a Matter of Numbers?

Cristian Surcel  1 , Alexander Kretschmer  2 , Cristian Mirvald  1 , Ioanel Sinescu  1 , Isabel Heidegger  3 , Igor Tsaur  4
Affiliations
Review

Molecular Mechanisms Related with Oligometastatic Prostate Cancer-Is It Just a Matter of Numbers?

Cristian Surcel et al. Cancers (Basel). .

Abstract

During the last decade, the body of knowledge regarding the oligometastatic state has increased exponentially. Several molecular frameworks have been established, aiding our understanding of metastatic spread caused by genetically unstable cells that adapt to a tissue environment which is distant from the primary tumor. In the current narrative review, we provide an overview of the current treatment landscape of oligometastatic cancer, focusing on the current biomarkers used in the identification of true oligometastatic disease and highlighting the impact of molecular imaging on stage shift in different scenarios. Finally, we address current and future directions regarding the use of genetic and epigenetic targeting treatments in oligometastatic prostate cancer.

Keywords: PET CT; biomarkers; genes; microRNA; oligometastatic prostate cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Gupta G.P., Massague J. Cancer metastasis: Building a framework. Cell. 2006;127:679–695. doi: 10.1016/j.cell.2006.11.001. - DOI - PubMed
    1. Gutiontov S., Pitroda S., Weichselbaum R. The spectrum of metastasis: An opportunity for cure? Semin. Radiat. Oncol. 2021;31:174–179. doi: 10.1016/j.semradonc.2021.02.004. - DOI - PubMed
    1. Hellman S., Weichselbaum R.R. Oligometastases. J. Clin. Oncol. 1995;13:8–10. doi: 10.1200/JCO.1995.13.1.8. - DOI - PubMed
    1. Massaut E., Bohlok A., Lucidi V., Hendlisz A., Klastersky J.A., Donckier V. The concept of oligometastases in colorectal cancer: From the clinical evidences to new therapeutic strategies. Curr. Opin. Oncol. 2018;30:262–268. doi: 10.1097/CCO.0000000000000453. - DOI - PubMed
    1. Deek M.P., Phillips R.M., Tran P.T. Local therapies in oligometastatic and oligoprogressive prostate cancer. Semin. Radiat. Oncol. 2021;31:242–249. doi: 10.1016/j.semradonc.2021.03.007. - DOI - PMC - PubMed

LinkOut - more resources